Key result
AAV-mediated expression of IFN-γ induced pronounced cardiac metabolic reprogramming with reduced mitochondrial oxygen consumption and a shift toward glycolysis.
Why the study?
Interferon-gamma regulates myocardial inflammation and fibrosis, but its direct effects on cardiomyocytes remain poorly understood.
Does elevated systemic IFN-γ induce cardiac metabolic reprogramming in mice?
Does elevated systemic IFN-γ induce cardiac metabolic reprogramming in mice?
Characterizes interferon gamma's impact on cardiac metabolism in mice, suggesting new insights into heart failure mechanisms.
Interferon-γ (IFN-γ) plays a central role in regulating myocardial inflammation and fibrosis and is relevant across different disease contexts, including ischemic and non-ischemic heart failure. However, the direct effects of IFN-γ on cardiomyocytes remain poorly understood. The aim of this study was therefore to characterize the influence of IFN-γ on cardiac metabolism and subsequent heart function using a novel in vivo model without concomitant myocardial disease or other confounding factors. To this end, male C57BL/6J mice were intravenously injected with a hepatotropic adeno-associated virus (AAV2/8) expressing Ifng and nLuc reporter under the control of the albumin promoter (AAV-Ifng) or with a control virus (AAV-ctrl). On day 28, comprehensive analyses of cardiac changes were performed, including flow cytometry, bulk RNA sequencing, targeted metabolomics, measurements of isolated mitochondrial activity, echocardiography, and in vivo imaging with [\(¹⁸\)F]fluorodeoxyglucose and [\(¹⁸\)F]fluoro-6-thia-heptadecanoic acid. In addition, mice with a cardiomyocyte-specific knockout of the IFN-γ receptor (Myh6\(Cre\) Ifngr1\(fl/fl\)) were analyzed to investigate cell-intrinsic effects of IFN-γ signaling on the metabolic reprogramming of cardiomyocytes. After confirming liver-specific transfection and physiologically elevated serum levels of IFN-γ, AAV-Ifng–treated animals displayed pronounced metabolic reprogramming of the heart. RNA sequencing identified a significant IFN-γ response signature accompanied by downregulation of oxidative phosphorylation and fatty acid oxidation. Functional analyses revealed reduced mitochondrial oxygen consumption, while metabolomics confirmed a shift toward glycolysis. These findings were supported by in vivo PET imaging, which demonstrated increased cardiac glucose uptake following AAV-Ifng treatment. These changes were absent in the Myh6\(Cre\) Ifngr1\(fl/fl\) model, underscoring the direct role of the cardiomyocyte IFN-γ receptor in mediating the observed reprogramming. These results indicate that IFN-γ, beyond its classical role in inflammation, acts as a central regulator of cardiac metabolism, thereby providing new potential mechanistic insights into immunological control of heart failure.
No takes yet. Share an insight, caveat, or question.
Ebram Melika (2026) studied Cardiac metabolic reprogramming. AAV-Ifng (Interferon-gamma expression) vs. AAV-ctrl (control virus) was evaluated on Cardiac metabolic reprogramming. AAV-mediated expression of IFN-γ induced pronounced cardiac metabolic reprogramming with reduced mitochondrial oxygen consumption and a shift toward glycolysis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: